Something is coming for GRPHDid a google search on the advancements in medical science and it is said that we are moving at an exceptional rate, doubling in its movement every few months.
Graphite Bio is a gene-editing company. Without doing much research on the company itself I know that this area is a sizeable area of resea
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−7.07 USD
−124.65 M USD
0.00 USD
22.36 M
About LENZ Therapeutics, Inc.
Sector
CEO
Evert B. Schimmelpennink
Headquarters
Solana Beach
Website
Founded
2013
FIGI
BBG00XDH4NZ2
LENZ Therapeutics, Inc. operates as a clinical stage company, which develops ophthalmic pharmaceutical products. It offers eye drop product treatment for presbyopia. The company was founded by James McCollum in July 2013 and is headquartered in Solana Beach, CA.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of LENZ is 32.63 USD — it has increased by 7.76% in the past 24 hours. Watch LENZ Therapeutics, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange LENZ Therapeutics, Inc. stocks are traded under the ticker LENZ.
LENZ stock has risen by 7.16% compared to the previous week, the month change is a −5.23% fall, over the last year LENZ Therapeutics, Inc. has showed a 103.56% increase.
We've gathered analysts' opinions on LENZ Therapeutics, Inc. future price: according to them, LENZ price has a max estimate of 44.00 USD and a min estimate of 36.00 USD. Watch LENZ chart and read a more detailed LENZ Therapeutics, Inc. stock forecast: see what analysts think of LENZ Therapeutics, Inc. and suggest that you do with its stocks.
LENZ reached its all-time high on Jun 30, 2021 with the price of 238.00 USD, and its all-time low was 11.13 USD and was reached on Jan 6, 2023. View more price dynamics on LENZ chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
LENZ stock is 16.49% volatile and has beta coefficient of 0.93. Track LENZ Therapeutics, Inc. stock price on the chart and check out the list of the most volatile stocks — is LENZ Therapeutics, Inc. there?
Today LENZ Therapeutics, Inc. has the market capitalization of 897.35 M, it has decreased by −1.85% over the last week.
Yes, you can track LENZ Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
LENZ Therapeutics, Inc. is going to release the next earnings report on Mar 18, 2025. Keep track of upcoming events with our Earnings Calendar.
LENZ earnings for the last quarter are −0.38 USD per share, whereas the estimation was −0.46 USD resulting in a 17.06% surprise. The estimated earnings for the next quarter are −0.41 USD per share. See more details about LENZ Therapeutics, Inc. earnings.
LENZ Therapeutics, Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
LENZ net income for the last quarter is −10.21 M USD, while the quarter before that showed −10.25 M USD of net income which accounts for 0.38% change. Track more LENZ Therapeutics, Inc. financial stats to get the full picture.
As of Dec 22, 2024, the company has 6.00 employees. See our rating of the largest employees — is LENZ Therapeutics, Inc. on this list?
Like other stocks, LENZ shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade LENZ Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So LENZ Therapeutics, Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating LENZ Therapeutics, Inc. stock shows the buy signal. See more of LENZ Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.